SOTERA HEALTH COMPANY Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
SOTERA HEALTH COMPANY (SHC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $2.26 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-24
- SOTERA HEALTH COMPANY effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $2.26M, a 41.54% decline from fiscal 2024.
- SOTERA HEALTH COMPANY effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $3.86M, a 20.90% increase from fiscal 2023.
- SOTERA HEALTH COMPANY effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $3.19M, a 27.17% increase from fiscal 2022.
- SOTERA HEALTH COMPANY effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $2.51M, a 66.01% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-31 | $2.26M 10-K · filed 2026-02-24 |
| 2024-12-31 | $3.86M 10-K · filed 2026-02-24 |
| 2023-12-31 | $3.19M 10-K · filed 2026-02-24 |
| 2022-12-31 | $2.51M 10-K · filed 2025-02-27 |
| 2021-12-31 | $1.51M 10-K · filed 2024-02-27 |
| 2020-12-31 | $2.05M 10-K · filed 2023-02-28 |
| 2019-12-31 | $3.54M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |